Pramod K. Kuchulakanti, MD

Safety of Percutaneous Coronary Intervention Alone in Symptomatic Patients with Moderate and Severe Valvular Aortic Stenosis and

08/01/2008

Lowell F. Satler , MD;

Kenneth M. Kent , MD, PhD;

Pramod K. Kuchulakanti , MD;

Augusto D. Pichard , MD, FACC, FSCAI;

Daniel A. Canos , MPH;

William O. Suddath , MD;

Ellen E. Pinnow , MS;

Seung-Woon Rha , MD, PhD;

Edouard Cheneau , MD;

Neil J. Weissman , MD;

Rajbabu Pakala , MD, PhD;

Ron Waksman , MD;

Aortic stenosis (AS) is prevalent in 2–7% of the population over 65 years of age.1 Atherosclerotic coronary artery disease (CAD) coexists in 27–43% of patients with AS.2 Management of CAD in patients with AS poses special problems since...

Aortic stenosis (AS) is...

08/01/2008

Journal of Invasive Cardiology

Impact of Continued Hospitalization in Patients Pre-treated with Clopidogrel Prior to Coronary Angiography and Undergoing Corona

08/01/2008

Ron Waksman , MD;

William O. Suddath , MD;

Lowell F. Satler , MD;

Seung-Woon Rha , MD, PhD;

Kenneth M. Kent , MD, PhD;

Augusto D. Pichard , MD, FACC, FSCAI;

Pramod K. Kuchulakanti , MD;

Edouard Cheneau , MD;

Robert Lew , MD;

Rajbabu Pakala , MD, PhD;

Emmanouil I. Kapetanakis ;

Elizabeth Haile ;

Paul Corso ;

Clopidogrel is an oral antiplatelet agent which selectively and irreversibly inhibits the platelet adenosine 5'-diphosphate (ADP) receptor. Antiplatelet effect is synergistic when administered with aspirin. Dual antiplatelet therapy with...

Clopidogrel is an oral...

08/01/2008

Journal of Invasive Cardiology

Case Report

Mechanisms and Methods to Resolve Edge Effect

08/01/2008

Pramod K. Kuchulakanti , MD;

Robert Lew , MD;

Ron Waksman , MD;

Vascular brachytherapy (VBT) has evolved as a viable method to treat in-stent restenosis (ISR), which is due to neointimal hyperplasia distributed either focally or diffusely over the entire length of the stent.1 Radiation acts by inhibiting...

Vascular brachytherapy (VBT) has...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Clinical Outcomes after Percutaneous Coronary Intervention with Drug-Eluting Stents in Dialysis Patients

08/01/2008

William O. Suddath , MD;

William W. Chu , MD, PhD;

Neil J. Weissman , MD;

Ron Waksman , MD;

Salah-Eddine Hassani , MD;

Zhenyi Xue , MS;

Roswitha M. Wolfram , MD;

Lowell F. Satler , MD;

Pramod K. Kuchulakanti , MD;

Kenneth M. Kent , MD, PhD;

Natalie Gevorkian , MD;

Augusto D. Pichard , MD, FACC, FSCAI;

The major cause of mortality in dialysis patients is attributable to cardiovascular diseases.1,2 The higher prevalence of coronary artery disease in this population is thought to be related to a higher risk factor distribution, platelet...

The major cause of mortality in...

08/01/2008

Journal of Invasive Cardiology